Beyond statins: What you need to know about alternative lipid-lowering agents Wrist-worn heart monitors not always accurateValidation ‘imperative’ for serious clinical use, researchers say Case Report: A patient with familial dyslipidemia fails to respond to statins Got patients with a-fib? You need to read this Recent studies evaluate biomarkers for risk assessment and compare oral anticoagulants Pharmacist-directed dyslipidemia care improves cholesterol management Pharmacist prescribing and monitoring of lipid-lowering therapy enables more patients with uncontrolled dyslipidemia to reach LDL-C targets. A heart attack is hard on younger patients’ sex life Women suffer more than men in the year after an acute MI, study finds Psoriasis and heart disease: ‘Major educational efforts’ needed Coronary arteries in just as bad a shape as those in type 2 diabetes patients Patient doing well on warfarin? Check again Stability is elusive for patients on long-term anticoagulation 2016 Canadian dyslipidemia guidelines Despite controversy, experts continue to recommend LDL-C targets for patients started on lipid-lowering therapy. Watch for drugs that can cause or worsen heart failure New AHA statement identifies potentially problematic drugs and provides tips for minimizing polypharmacy. First Previous 34 35 36 37 38 Next Last